サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：デジタル治療市場：製品タイプ別、販売チャネル別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1304616

デジタル治療市場：製品タイプ別、販売チャネル別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Digital Therapeutics Market with COVID-19 Impact Analysis, By Product Type, By Sales Channel, By Applications, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日
ページ情報
英文 295 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
デジタル治療市場：製品タイプ別、販売チャネル別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年06月01日
発行: AnalystView Market Insights
ページ情報: 英文 295 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

デジタル治療市場規模は2022年に47億7,100万米ドルとなり、2023年から2030年にかけてCAGR 33.9％で拡大

デジタル治療市場-市場力学：

医療費抑制に対する要求の高まり、ヘルスケアアプリケーションと連動したタブレット＆スマートフォンの使用の増加、ヘルスケア全プロセスの利点、慢性疾患罹患率の上昇が、世界のデジタル治療市場の需要を促進すると思われます。しかし、治療用製品には、誤った情報や過剰な予測結果などの限界があり、デジタル治療の市場成長を抑制する可能性があります。

さらに、患者や医療提供者にとってのデジタル医療技術の費用対効果、統合医療システムに対する要求の高まり、患者中心のケアは、デジタル治療市場に大きな機会を提供することに貢献しています。COVID-19パンデミックはデジタル治療市場にプラスの影響を与えました。精神疾患の有病率の増加、デジタルヘルスの重要性に関する認識、世界の薬物乱用率の増加などです。さらに、パンデミックと政府の厳しい規制の間、人々は家にいなければならず、不健康なライフスタイル、身体活動の減少、精神的ストレスにつながり、これがひいてはデジタル治療の需要を増加させると予想される慢性疾患の症例を増加させました。

デジタル治療市場-セグメンテーション分析：

  • 世界のデジタル治療市場は、製品タイプ、販売チャネル、用途、地域によって区分されます。
  • 製品タイプにより、市場はソフトウェアとデバイスの2つに分類されます。ソフトウェア分野は今後も優位性を維持するとみられます。長期的な行動変容をもたらす個別化ケアと相まって、患者の服薬アドヒアランスを支援します。
  • 市場は販売チャネルによって、企業対企業（B2B）と企業対消費者（B2C）の2つに分類されます。B2B分野が最大の市場シェアを占めると予想されます。支払者、雇用者、医療提供者の間でデジタル治療の利点に対する認識が高まっていることが、この分野の需要増加につながっています。
  • 市場は用途別に、糖尿病、肥満、心血管疾患（CVD）、実際の中枢神経系（CNS）の疾患、呼吸器疾患、禁煙、胃腸疾患、その他の7つに分類されます。予測期間中、糖尿病分野が市場を牽引する可能性が高いです。ニーズの高まりと認知度の急上昇は、糖尿病の正確な管理のためにこの治療薬が提供する様々な利点に関連しています。

デジタル治療市場-競合情勢：

デジタル治療は、個別化された治療プログラムや、市場プレーヤーが採用するさまざまな戦略により、病状を抱える患者にとって重要な治療選択肢となっています。さらに、市場プレーヤーが採用する戦略には、製品の承認、新製品の発売、提携、共同研究、研究開発費、M&A、流通網の開拓などがあります。さらに、糖尿病、心臓病、不安障害などの慢性疾患の増加により、主要プレイヤーは市場でのデジタル治療を追求するように促されています。例えば、2023年1月、Lupinはホリスティック・ハートケアのためのデジタル治療ソリューションLYFEの発売を発表しました。さらに、これはインドで唯一のエビデンスに基づくホリスティック・ハート・ケア・プログラムであり、心臓発作のリスクを大幅に最小化し、心臓病患者の生活の質とバイタルを改善します。

研究の主な特徴

  • デジタル治療市場に関するこの調査レポートは、2022年を基準年として、市場規模、CAGR、推定・予測（2023-2030年）を提供しています。
  • 調査レポートは、さまざまなセグメント/国にわたる潜在的な成長機会を解明し、デジタル治療市場の魅力的な投資提案マトリクスを解説しています。
  • 全体的なレポートでは、新たな投資機会、既存企業が直面する課題、デジタル治療市場で持続するための成長要因を特定しています。
  • COVID-19がデジタル治療市場規模、予測、CAGR、市場力学に与える影響については、調査範囲で詳細に論じています。COVID後のデジタル治療市場に関する詳細な洞察もカバーします。
  • 本レポートのユーザーにデジタル治療市場の包括的な見解を提供するため、デジタル治療市場の競合情勢や主要イノベーター分析も掲載しています。
  • 本調査では、市場規模、成長率、魅力度に基づき、すべての業界セグメントをベンチマークとした成長見通しマッピング分析を網羅しています。
  • 主要市場参入企業の詳細な企業プロファイルを掲載しており、デジタル治療市場で事業を展開する企業の財務情報や戦略的イニシアチブを理解するのに役立ちます。
  • さらに、世界レベルだけでなく地域レベルでも、市場に関わる主要参入企業の重要な買収・合併、提携・合弁事業、新発売、研究開発、地域展開についても明らかにしています。
  • 世界のデジタル治療市場レポートは主に、サプライヤー、投資家、新規参入者、流通業者、金融アナリストなど、この業界のさまざまな利害関係者を対象としています。

目次

第1章 デジタル治療市場概要

  • 調査範囲

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 デジタル治療の主要な市場動向

  • デジタル治療市場促進要因
  • デジタル治療市場抑制要因
  • デジタル治療の市場機会
  • デジタル治療市場の今後の動向

第4章 デジタル療法産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 デジタル治療市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 デジタル治療市場情勢

  • デジタルセラピューティクス市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 デジタル治療市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • ソフトウェア
    • デバイス

第8章 デジタル治療市場- 販売チャネル別

  • 概要
    • 販売チャネル別セグメントシェア分析
    • 企業間（B2B）
    • 企業対消費者（B2C）

第9章 デジタル治療市場- 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 糖尿病
    • 肥満
    • 心血管疾患（CVD）
    • 実際の中枢神経系（CNS）の病気
    • 呼吸器の状態
    • 禁煙
    • 胃腸の問題
    • その他

第10章 デジタル治療市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米のデジタル治療の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州のデジタル治療の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域のデジタル治療の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカのデジタル治療の主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカのデジタル治療の主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- デジタル治療産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Click Therapeutics, Inc.
    • Proteus Digital Health, Inc.
    • Pear Therapeutics
    • Welldoc, Inc.
    • 2MORROW, Inc.
    • Happify
    • Fitbit, Inc.（Twine Health, Inc.）
    • Resmed, Inc.（Propeller Health）
    • Medtronic Plc.
    • Kaia Health
    • Akili Interactive Labs, Inc.
    • Livongo Health, Inc.
    • Omada Health, Inc.
    • Voluntis, Inc.

第12章 アナリストの全方位的展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Digital Therapeutics Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Digital Therapeutics Market, by Product Type2018-2030 (USD Million)
  • TABLE Digital Therapeutics Market: Sales ChannelSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Sales Channel
  • TABLE Global Digital Therapeutics Market, by Sales Channel2018-2030 (USD Million)
  • TABLE Digital Therapeutics Market: Regional snapshot (2022)
  • TABLE Digital Therapeutics Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Digital Therapeutics Market, by Application 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Digital Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Digital Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Digital Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Digital Therapeutics Market, by Sales Channel, 2018-2030 (USD Million)
  • TABLE North America Digital Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Digital Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Digital Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE EuropeDigital Therapeutics Market, by Sales Channel, 2018-2030 (USD Million)
  • TABLE Europe Digital Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Digital Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Digital Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Digital Therapeutics Market, by Sales Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Digital Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Digital Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Digital Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Digital Therapeutics Market, by Sales Channel, 2018-2030 (USD Million)
  • TABLE Latin America Digital Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Digital Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Digital Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Digital Therapeutics Market, by Sales Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Digital Therapeutics Market, by Application, 2018-2030 (USD Million)
目次
Product Code: ANV1374

REPORT HIGHLIGHT

Digital therapeutics market size was valued at USD 4,771.0 Million in 2022, expanding at a CAGR of 33.9% from 2023 to 2030.

Digital therapeutics refers to hardware and software that digitally preserve evidence-based therapeutic actions for the prevention and management of the disease. Additionally, the software and tools support the management of various ailments connected to respiratory, cardiovascular, and mental health issues. Moreover, increasing case of chronic diseases like cancer, heart failure, diabetes, and mental illness is a factor attributed to the rising demand for this market.

Digital Therapeutics Market- Market Dynamics:

The rising requirement to control healthcare costs, increasing use of tablets & smartphones coupled with healthcare applications, advantages of the entire process of healthcare, and rising chronic disease incidence is likely to propel the demand for the global digital therapeutics market. However, therapeutic products have their limitations including false information and over-predictive results which may restrain the market growth of digital therapeutics.

Furthermore, the cost-effectiveness of digital health technologies for patients and providers, the increasing requirement for integrated health systems, and patient-centered care contributed to offering massive opportunities for the digital therapeutics market. The COVID-19 pandemic impacted the digital therapeutics market positively. The increase in the prevalence of mental illness, awareness regarding the importance of digital health, and the increase in the rate of drug abuse worldwide. In addition, during the pandemic and government stringent regulation people had to stay at home, which led to unhealthy lifestyles, less physical activity, and mental stress this in turn increased the case of chronic disease which is anticipated to increase the demand for digital therapeutics.

Digital Therapeutics Market- Segmentation Analysis:

  • The global digital therapeutics market is segmented on the basis of product type, sales channel, applications, and region.
  • The market is divided into two categories based on product type: software and devices. The software sector is likely to maintain its dominance. It assists patients with medication adherence coupled with personalized care that provides long-term behavioral change.
  • The market is divided into two categories based on sales channel: business-to-business (B2B) and business-to-consumers (B2C). The B2B sector is expected to hold the largest market share. The rising awareness among payers, employers, and providers about the advantages of digital therapeutics is attributed to an increase in the demand for this segment.
  • The market is divided into seven categories based on application: diabetes, obesity, cardiovascular disease (CVD), diseases of the actual central nervous system (CNS), respiratory conditions, quitting smoking, gastrointestinal problems, and others. The diabetes sector is likely to possess the market over the forecast period. The rising need and surging awareness are associated with various advantages provided by this therapeutics for the precise management of diabetes.

Digital Therapeutics Market-Competitive Landscape:

For patients with medical conditions digital therapeutics has become an important treatment option due to personalized treatment programs and various strategies adopted y market players, Additionally, the strategies adopted by the market players include, product approval, new product launches, partnership, collaboration, R&D spending, mergers & acquisitions, and distribution network development. Moreover, the rising chronic disease cases such as diabetes, heart disease, and anxiety disorders have prompted key players to pursue digital treatment in the market. For instance, in January 2023, Lupin announced the launch of LYFE, its Digital Therapeutic Solution for Holistic Heart Care. Additionally, it is only evidence-based holistic heart care program in India's, which significantly minimizes the risk of a heart attack and improves quality and vitals of life for cardiac patients.

Key features of the study:

  • This proposed research study on digital therapeutics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for digital therapeutics market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the digital therapeutics market.
  • Impact of COVID-19 on digital therapeutics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on digital therapeutics market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the digital therapeutics market, we have also included competitive landscape and key innovator analysis for the digital therapeutics market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the digital therapeutics market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global digital therapeutics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIGITAL THERAPEUTICS MARKET KEY PLAYERS

  • Click Therapeutics, Inc.
  • Proteus Digital Health, Inc.
  • Pear Therapeutics
  • Welldoc, Inc.
  • 2MORROW, Inc.
  • Happify
  • Fitbit, Inc. (Twine Health, Inc.)
  • Resmed, Inc. (Propeller Health)
  • Medtronic Plc.
  • Kaia Health
  • Akili Interactive Labs, Inc.
  • Livongo Health, Inc.
  • Omada Health, Inc.
  • Voluntis, Inc.

GLOBALDIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE

  • Software
  • Devices

GLOBAL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL

  • Business-to-business (B2B)
  • Business-to-consumers (B2C)

GLOBAL DIGITAL THERAPEUTICS MARKET, BY APPLICATIONS

  • Diabetes
  • Obesity
  • Cardiovascular Disease (CVD)
  • Diseases of the actual Central Nervous System (CNS)
  • Respiratory Conditions
  • Quitting Smoking
  • Gastrointestinal Problems
  • Others

GLOBAL DIGITAL THERAPEUTICS MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Digital Therapeutics Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Digital Therapeutics Market Snippet by Product Type
    • 2.1.2. Digital Therapeutics Market Snippet by Sales Channel
    • 2.1.3. Digital Therapeutics Market Snippet by Application
    • 2.1.4. Digital Therapeutics Market Snippet by Country
    • 2.1.5. Digital Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Digital Therapeutics Key Market Trends

  • 3.1. Digital Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Digital Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Digital Therapeutics Market Opportunities
  • 3.4. Digital Therapeutics Market Future Trends

4. Digital Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Digital Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Digital Therapeutics Market Landscape

  • 6.1. Digital Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Digital Therapeutics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022&2030 (%)
    • 7.1.2. Software
    • 7.1.3. Devices

8. Digital Therapeutics Market - By Sales Channel

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Sales Channel, 2022&2030 (%)
    • 8.1.2. Business-to-business (B2B)
    • 8.1.3. Business-to-consumers (B2C)

9. Digital Therapeutics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 9.1.2. Diabetes
    • 9.1.3. Obesity
    • 9.1.4. Cardiovascular Disease (CVD)
    • 9.1.5. Diseases of the actual Central Nervous System (CNS)
    • 9.1.6. Respiratory Conditions
    • 9.1.7. Quitting Smoking
    • 9.1.8. Gastrointestinal Problems
    • 9.1.9. Others

10. Digital Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Digital Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Digital Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Digital Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Digital Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Digital Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Digital Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Click Therapeutics, Inc.
    • 11.2.2. Proteus Digital Health, Inc.
    • 11.2.3. Pear Therapeutics
    • 11.2.4. Welldoc, Inc.
    • 11.2.5. 2MORROW, Inc.
    • 11.2.6. Happify
    • 11.2.7. Fitbit, Inc. (Twine Health, Inc.)
    • 11.2.8. Resmed, Inc. (Propeller Health)
    • 11.2.9. Medtronic Plc.
    • 11.2.10. Kaia Health
    • 11.2.11. Akili Interactive Labs, Inc.
    • 11.2.12. Livongo Health, Inc.
    • 11.2.13. Omada Health, Inc.
    • 11.2.14. Voluntis, Inc.

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us